Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy

被引：0
|
作者：
Hazim, A. [1 ]
Xiao, A. [1 ]
Singh, A. [1 ]
Chung, K. [2 ]
dos Santos, P. A. Reck [2 ]
D'Cunha, J. [2 ]
Shanshal, M. [1 ]
Dimou, A. [1 ]
Parikh, K. [1 ]
Lou, Y. [3 ]
Manochakian, R. [3 ]
Leventakos, K. [1 ]
Molina, J. [1 ]
Mansfield, A. [1 ]
Ernani, V. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Mayo Clin, Jacksonville, FL 32224 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
chemoimmunotherapy; neoadjuvant; non small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07C.16
引用
收藏
页码：S546 / S547
页数：2
相关论文
共 50 条
  • [41] Real-World Outcomes Among Advanced Non-Small Cell Lung Cancer Patients Re-Treated with Immunotherapy in the US
    Spira, A.
    Monnette, A.
    Wentworth, C.
    Doan, J.
    Chang, C.
    Hartman, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S189 - S190
  • [42] Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study
    Li, Jialong
    Wang, Youyu
    Zhao, Zerui
    Wang, Sihua
    Yan, Wanpu
    Chen, Xiaohui
    Chen, Tianxiang
    Li, Pengfei
    Wang, Sheng
    Fang, Qiang
    Peng, Lin
    Han, Yongtao
    Tang, Jian
    Leng, Xuefeng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (12) : 3344 - 3351
  • [43] Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021
    Jessie T. Yan
    Yue Jin
    Ernest Lo
    Yilin Chen
    Amy E. Hanlon Newell
    Ying Kong
    Landon J. Inge
    Oncology and Therapy, 2023, 11 : 343 - 360
  • [44] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer
    Lochrin, Sarah E.
    Forde, Patrick M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (08) : 415 - 423
  • [45] Neoadjuvant therapy for resectable non-small cell lung cancer
    Welcker, Katrin
    Jonigk, Danny
    Kropf-Sanchen, Cornelia
    Tufman, Amanda
    Draube, Andreas
    Stenzinger, Albrecht
    Zaatar, Mohamed
    Thomas, Michael
    PNEUMOLOGIE, 2025, 79 (01): : 16 - 24
  • [46] Adjuvant Chemotherapy in Elderly Patients with Early-stage Non-small Cell Lung Cancer
    Kefeli, Umut
    Kaymaz, Samet
    Aydin, Dincer
    Isik, Deniz
    Cabuk, Devrim
    Sonkaya, Alper
    Acikgoz, Ozgur
    Isik, Ulas
    Ozden, Ercan
    Uygun, Kazim
    BEZMIALEM SCIENCE, 2019, 7 (04): : 265 - 270
  • [47] Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011-2021
    Yan, Jessie T. T.
    Jin, Yue
    Lo, Ernest
    Chen, Yilin
    Newell, Amy E. Hanlon E.
    Kong, Ying
    Inge, Landon J. J.
    ONCOLOGY AND THERAPY, 2023, 11 (03) : 343 - 360
  • [48] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Non-small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis
    Syaj, S.
    Akhdar, M.
    Ababneh, O.
    Hamouri, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S235 - S236
  • [49] Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting
    Rizzo, Manglio Miguel
    Bluthgen, Maria Virginia
    Recondo, Gonzalo
    Naveira, Martin
    Perfetti, Aldo
    Rizzi, Florencia
    Kuzminin, Alejandro
    Faura, Victoria
    Cerini, Matias
    Videla, Alejandro
    Silva, Carlos
    Lupinacci, Lorena
    Minatta, Nicolas
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (06) : 1057 - 1064
  • [50] Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting
    Manglio Miguel Rizzo
    María Virginia Bluthgen
    Gonzalo Recondo
    Martin Naveira
    Aldo Perfetti
    Florencia Rizzi
    Alejandro Kuzminin
    Victoria Faura
    Matías Cerini
    Alejandro Videla
    Carlos Silva
    Lorena Lupinacci
    Nicolás Minatta
    International Journal of Clinical Oncology, 2021, 26 : 1057 - 1064
12345